Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9908
+0.0253 (2.62%)
At close: Sep 16, 2025, 4:00 PM EDT
0.9999
+0.0091 (0.92%)
After-hours: Sep 16, 2025, 4:57 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $35.85 million as of September 16, 2025. Its market cap has decreased by -10.59% in one year.
Market Cap
35.85M
Enterprise Value
35.01M
1-Year Change
-10.59%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $35.85M, a decrease of -62.18%. That is a compound annual growth rate of -14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 35.00M | -32.43% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |